247 The efficacy of anti-cd20 antibody rituximab for refractory patients with systemic lupus erythematosus | Lupus Science & Medicine

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Podcasts
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

Poster Session

Clinical trials

247 The efficacy of anti-cd20 antibody rituximab for refractory patients with systemic lupus erythematosus

Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Iwata S, Saito K, Ohkubo N, et al

247 The efficacy of anti-cd20 antibody rituximab for refractory patients with systemic lupus erythematosus

Lupus Science & Medicine 2017;4:doi: 10.1136/lupus-2017-000215.247